Home
>
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals close over 1% higher, trims most of early gains
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals' Q1 net profit up 24% at Rs 227 cr
3224 Days ago
Glenmark Pharmaceuticals
Glenmark gets two ANDA approvals from USFDA
3361 Days ago
Glenmark Pharmaceuticals
Glenmark seeks shareholders' nod to raise up to $500 million
3456 Days ago
Glenmark Pharmaceuticals
Glenmark gets USFDA final nod for anti-bacterial drug
3458 Days ago
L&T
Corporate Earnings: Top gainers and losers in Q2 results announced today
3511 Days ago
Glenmark Pharmaceuticals
Glenmark Pharma scrip gains 6% post Q2 earnings
3511 Days ago
Glenmark Pharmaceuticals
Glenmark Q2 net up 20% at Rs 198 crore
3512 Days ago
Glenmark Pharmaceuticals
Glenmark evaluating legal options over diabetes drugs setback
3533 Days ago
Glenmark Pharmaceuticals
Blow to Glenmark: HC restrains it from making anti-diabetes drugs
3534 Days ago
Glenmark Pharmaceuticals
Glenmark Pharma eyes US biz to be strong growth driver
3549 Days ago
India drugmaker
India drugmaker stocks exception in Asian rout
3568 Days ago
Glenmark Pharmaceuticals
Glenmark receives USFDA nod for oral contraceptive drug
3583 Days ago
Glenmark Pharmaceuticals
Glenmark Q1 net up 3.29% at Rs 191 crore
3603 Days ago
Glenmark Pharmaceuticals
Glenmark gets USFDA final nod for contraceptive tablets
3648 Days ago
Glenmark Pharmaceuticals
Glenmark gets final USFDA nod for psoriasis cream
3652 Days ago
Glenmark Pharmaceuticals
Glenmark issues over 1 cr shares to Aranda, raises Rs 945 cr
3675 Days ago
Glenmark Pharmaceuticals
FIIs can now invest up to 49% in Glenmark Pharma
3675 Days ago
Glenmark Pharmaceuticals
Supreme Court bars Glenmark from selling Merck drug copies
3679 Days ago
Glenmark Pharmaceuticals
Glenmark gets tentative USFDA nod for generic psoriasis cream
3690 Days ago